Marketing-authorisation holder
Alfasan Nederland B.V.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALFAGLANDIN C250 mcg / ml · Solution | Cloprostenol | Canada | Not marketed | 2016 |
| PREDNISOLONE 5 MG TABLETS5 mg · Tablet | Prednisolone | Canada | Marketed | 2007 |
| VITAMIN AD3 FORTE500000 unit / ml + 75000 unit / ml · Solution | Vitamin a, Vitamin d | Canada | Not marketed | 2004 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- alfasan nederland
- alfasan nederland b v
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder